IL-13 protects from Clostridioides difficile colitis
Alexandra N. Donlan(University of Virginia), William A. Petri(University of Virginia)
Cited by 7
Related Papers
IL-13 is a driver of COVID-19 severity
|JCI Insight|2021|159
IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
|Nature Communications|2019|137
IL-13 is a driver of COVID-19 severity
|medRxiv|2020|73
The IL-33-ILC2 pathway protects from amebic colitis
|bioRxiv (Cold Spring Harbor Laboratory)|2021|1
IL-13 promotes recovery from <i>C. difficile</i> infection
|bioRxiv (Cold Spring Harbor Laboratory)|2021|1